Center for Medical Weight Loss review

This is one of the few places where the low-dose product is genuinely cheaper than the standard program, and the flat-price promise on that standard program is stated in unusually plain language. The trap is structural rather than numeric: the microdose is sold only as a three-month block, with no monthly option, so a reader who wants to try a low dose for a month cannot — they have to commit the full amount up front. No milligram range is published for either line, and the microdosing page makes claims about longevity and cognition that run well beyond what the evidence supports.

Vs median

Not comparable — published against a multi-month block with no monthly rung, so a per-month figure would be one we calculated rather than one they published

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Charges less for less

Consult

Included in the price

Dietitian

Included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Center for Medical Weight Loss does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

This is the direct-to-consumer arm of the Center for Medical Weight Loss, a physician-network weight-management brand that says it has treated over 500,000 patients since 2006. Commerce runs on a separate subdomain from the main brand site and sells compounded semaglutide and tirzepatide subscriptions plus a distinct GLP-1 microdosing line aimed at weight maintenance. Care is asynchronous — an online eligibility questionnaire, a prescription within 24 hours, delivery in three to five days — with an initial telemedicine consult with a U.S. board-certified physician. No pharmacy is named. There is no membership fee, and the program bundles a nutrition course, a maintenance guide and meal replacements.

A "THREE-MONTH" PLAN HERE BILLS EVERY 10 WEEKS. Its own terms put the cycle at "every 10 weeks" on an option that ships a 12-week supply — 5.2 charges a year instead of 4, so the yearly cost is roughly 30% higher than the advertised rate suggests, and the interval appears nowhere on the plan card

• The microdose line is sold ONLY as a three-month prepay. There is no monthly rung at all, so a microdoser must commit the full amount up front with no way to try a single month — a hidden minimum term on the one product a low-dose reader would come here for
• The plans homepage advertises only the three-month prepay figures and never surfaces the month-to-month rates beside them
• No milligram dose is published for either the standard program or the microdose line, so the flat-price promise has no stated ceiling
• No pharmacy is named, and no 503A or 503B designation is given
• The microdosing page claims GLP-1 microdosing has been proven to improve longevity, cognitive function, neuroprotection and inflammation, which overstates the evidence for sub-therapeutic dosing considerably
• Commerce lives on a separate subdomain from the main brand site, and the main domain publishes no prices at all
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Center for Medical Weight Loss is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose